Estratto di
Tribulus Terrestris
Multi-targeted herbal extract with mixed evidence for sexual function and modest endocrine effects
Tribulus terrestris (TT) is a traditional botanical supplement derived from a creeping vine native to tropical and subtropical regions. Modern research demonstrates that its steroidal saponin compounds exert multi-target effects on sexual function, hormonal markers, and cardiovascular health, though evidence quality varies considerably across therapeutic claims.
Tribulus terrestris demonstrates moderate evidence for sexual function improvement (particularly erectile dysfunction in men and sexual desire in women) through nitric oxide vascular mechanisms independent of testosterone. Evidence is limited for testosterone elevation (only in hypogonadal populations with modest 60-70 ng/dL increases), athletic performance (mostly negative), and sperm parameter improvement (moderate in oligozoospermia populations). Emerging theoretical potential exists for anti-inflammatory, neuroprotective, cardiovascular, and metabolic benefits, though human clinical trials are largely absent. Critical safety concerns include documented CYP3A4-mediated drug interactions causing rhabdomyolysis, hepatotoxicity, nephrotoxicity (rare case reports), and widespread commercial product contamination. Standardization challenges due to 70+ bioactive compounds with significant geographic variability (protodioscin content ranges 10-1330 mg/g) create unpredictability. Overall evidence quality is weakened by small sample sizes, methodological limitations in many studies, lack of long-term safety data beyond 90 days, and heterogeneity of preparation standardization.
Sexual Function in Men with Erectile Dysfunction
ModerateMultiple randomized controlled trials demonstrate that Tribulus terrestris supplementation at 400-1500 mg daily for 4-12 weeks improves erectile function scores (IIEF-5) and sexual satisfaction in men with documented erectile dysfunction. A systematic review of 10 clinical trials found that 3 of 5 studies investigating erectile dysfunction showed significant improvements in sexual parameters. The Bulgarian study (172 subjects, 1500 mg daily for 12 weeks) showed statistically significant improvements in intercourse satisfaction, orgasmic function, and sexual desire without altering total or free testosterone levels. Notably, improvements in sexual function occurred independent of hormonal changes, suggesting vasodilatory or neural mechanisms via nitric oxide upregulation.
Sexual Desire and Arousal in Women with Hypoactive Sexual Desire Disorder
ModerateA randomized double-blind placebo-controlled trial demonstrated that Tribulus terrestris extract at 7.5 mg daily for 4 weeks significantly improved sexual desire, arousal, lubrication, satisfaction, and pain domains of the Female Sexual Function Index (FSFI) in women with hypoactive sexual desire disorder during childbearing years. The improvement was statistically significant (p<0.001) with no reported adverse effects differentiating treatment from placebo groups. Proposed mechanisms include modulation of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) pathways, with animal studies suggesting increased follicle development and reproductive tissue thickening.
Sperm Parameters and Male Infertility
ModerateClinical evidence indicates that Tribulus terrestris supplementation improves semen quality parameters in men with oligozoospermia and unexplained infertility. Studies report improvements in sperm motility, morphology, and concentration, with some demonstrating increases of up to 104% in total sperm count. A 60-day trial using 12 g daily showed increased sperm motility and decreased abnormal forms. In vitro studies demonstrate protective effects against oxidative stress on spermatozoa. However, effects on testosterone levels in infertile men appear modest or absent; improvements in semen parameters appear independent of systemic androgenic effects.
Testosterone Level Modulation in Hypogonadal Men
LimitedSystematic evidence indicates that Tribulus terrestris has limited efficacy as a testosterone booster in healthy men or those with normal baseline androgens. Of 10 reviewed clinical trials, only 2 demonstrated statistically significant increases in total testosterone, and these occurred exclusively in men with documented hypogonadism, with modest improvements of 60-70 ng/dL. A meta-analysis concluded no robust evidence exists for increasing testosterone in men with normal baseline levels. Proposed mechanisms involve protodioscin-mediated FSH pathway stimulation rather than direct testosterone synthesis, accounting for selective effects in hypogonadal populations and spermatogenic improvements independent of systemic hormone elevation.
Cardiovascular and Endothelial Function
LimitedTribulus terrestris demonstrates cardiovascular-protective effects through multiple mechanisms in both preclinical and limited clinical models. Recent 2025 research in atherosclerotic mice (ApoE-/- model) showed that TT administration significantly reduced aortic plaque area, decreased serum triglycerides and LDL-cholesterol, and lowered inflammatory cytokines. Mechanistically, the saponin tigogenin suppresses TNF-α-mediated macrophage inflammation via NF-κB pathway inhibition. In vitro studies demonstrate that TT protects human endothelial cells against oxidized LDL-induced dysfunction by upregulating endothelial nitric oxide synthase (eNOS) and modulating JAK2/STAT3 and PI3K/AKT signaling pathways. Animal studies support antihypertensive effects through ACE inhibition, though human clinical data remain limited.
Blood Glucose Regulation in Diabetes
LimitedExperimental evidence demonstrates that Tribulus terrestris extracts reduce elevated blood glucose levels in streptozotocin-induced diabetic models through mechanisms likely involving inhibition of α-glucosidase and α-amylase enzymes. High-protodioscin content extracts showed significant fasting glucose reduction from week 1 of treatment. Both glucose tolerance and postprandial hyperglycemia appear improved. FSH and testosterone levels increased in TT-treated diabetic animals, suggesting endocrine modulation contributes to metabolic effects. However, human clinical trials are lacking; effects in healthy subjects show no glycemic changes, suggesting selectivity for dysglycemic states.
Anti-inflammatory and Antioxidant Activity
LimitedTribulus terrestris exerts potent anti-inflammatory effects through multiple pathways documented primarily in cellular models and animal studies. The flavonoid compound tribulusamide D inhibits LPS-induced production of nitric oxide and prostaglandin E2, reduces inflammatory cytokines (IL-6, IL-10, TNF-α), and suppresses NF-κB nuclear translocation and p38 MAPK phosphorylation. Antioxidant activity derives from polyphenolic compounds (0.6-3%) and flavonoids (0.04-0.5%) that scavenge hydroxyl, peroxyl, and superoxide radicals. In vivo studies demonstrate increased catalase and superoxide dismutase activity with decreased malondialdehyde (oxidative stress marker). These effects suggest potential protective roles in inflammation-associated conditions, though human clinical validation remains incomplete.
Bone Health and Osteoporosis
TheoreticalPreclinical evidence indicates that Tribulus terrestris standardized extract exerts bone-protective effects by increasing bone mineral density in an ovariectomy-induced osteoporosis rat model. TT treatment (3-300 mg/kg/day for 28 days) stimulated bone mass gain to levels comparable to sham-operated controls through mechanisms involving dehydroepiandrosterone (DHEA) elevation and calcium-sparing effects (reduced urinary calcium excretion). Histopathological analysis confirmed maintenance of normal bone turnover. Effects appear mediated through DHEA-dependent pathways rather than direct estrogen replacement. Human clinical data are absent; potential utility in postmenopausal and age-related bone loss remains theoretical.
Neuroprotection and Central Nervous System Function
TheoreticalEmerging research suggests potential neuroprotective effects through antioxidant and anti-inflammatory mechanisms. Zebrafish behavioral studies demonstrate that Tribulus terrestris administration induces significant anxiolytic and antidepressant-like effects in scopolamine-induced cognitive impairment models, with flavonoid compounds (kaempferol, quercetin, luteolin) showing molecular docking interactions with monoamine oxidase A (MAO-A). An ischemic stroke rat model (MCAO) showed that gross saponin Tribulus fruit extract administration significantly reduced brain infarction volume and improved neurobehavioral scores via suppression of the TLR4/MyD88/NF-κB inflammatory pathway. Additionally, tribuloside (a TT-derived flavonoid) ameliorated acute lung injury through PI3K/Akt pathway modulation. Human neurological studies are absent.
Urolithiasis (Kidney Stone) Prevention
LimitedTraditional medicine applications and preclinical research support a potential role for Tribulus terrestris in urinary stone management. Aqueous extracts demonstrate efficacy through multiple mechanisms: demineralization of existing stones, inhibition of new stone formation, increased urine volume (24-hour), and protective effects against renal injury via oxidative stress reduction and lipid peroxidation inhibition. Cellular studies show TT extract protects kidney cells (NRK-52E) from oxalate-induced damage in dose-dependent manner, suppressing both calcium oxalate crystal nucleation and growth while improving cell viability. However, human clinical trials evaluating therapeutic efficacy are absent; evidence remains primarily mechanistic and animal-based.
Athletic Performance and Body Composition
MixedEvidence for ergogenic or anabolic effects in athletes is weak and inconsistent. A double-blind study in elite rugby league players (450 mg/day TT vs. placebo for 5 weeks) found no significant improvements in strength, fat-free mass, or urinary testosterone/epitestosterone ratio compared to control. CrossFit athletes supplemented with 770 mg daily for 6 weeks showed no improvements in body composition, hormonal response, or perceived exertion versus placebo. Conversely, two studies reported improvements in anaerobic power and muscular capacity following 20 days of higher-dose TT (1875 mg), though these lacked rigorous controls. Manufacturer claims of 5-28 day muscle mass gains are not supported by peer-reviewed evidence. Any marginal effects may relate to increased recovery via improved testosterone/cortisol ratio rather than direct muscle protein synthesis stimulation.
Anticancer Potential
TheoreticalIn vitro and preclinical studies demonstrate that Tribulus terrestris extracts induce apoptosis in cancer cell lines (MCF-7 breast cancer, liver cancer cells) through both intrinsic (upregulation of Bax, p53; downregulation of Bcl-2) and extrinsic (FADD, AIF, caspase 8 upregulation) apoptotic pathways. Saponin fractions show highest cytotoxic activity with IC50 values indicating selective effects on cancer cells while sparing normal peripheral blood mononuclear cells. Bioactive components inhibit NF-κB signaling and cell cycle-related genes. Animal models show reduced tumor incidence and burden. However, no human cancer trials exist; mechanistic evidence remains confined to cell culture and animal xenograft models. Current data insufficient for therapeutic recommendations.
Antimicrobial and Anti-infective Properties
LimitedTribulus terrestris extracts (ethanol, chloroform, aqueous) demonstrate in vitro antimicrobial activity against multiple pathogenic bacteria and fungi. Ethanol extracts from fruits showed strongest activity with MIC values of 0.15 mg/mL against Gram-positive bacteria (B. subtilis, B. cereus, C. diphtheriae) and Gram-negative P. vulgaris. Antifungal activity demonstrated against C. albicans (MIC 0.62 mg/mL with aqueous extract; 0.15 mg/mL with ethanol extract). Traditional urinary anti-infective applications are scientifically validated against E. coli and other common urinary pathogens. Antimicrobial mechanisms likely involve saponin-induced membrane damage. However, human clinical trials evaluating therapeutic efficacy for infections are absent.
Ultimo aggiornamento: